Navigation Links
Experimental Drug Shows Promise Against Type 2 Diabetes
Date:2/27/2012

SUNDAY, Feb. 26 (HealthDay News) -- An experimental drug improves patients' blood sugar control without increasing the risk of low blood sugar (hypoglycemia) in patients with type 2 diabetes, according to the results of a phase 2 clinical trial.

Type 2 diabetes is the more prevalent form of the disease, accounting for about 90 percent of cases. Often tied to obesity, type 2 diabetes involves a gradual decline in how insulin responds to changes in blood sugar (glucose).

The new drug, called TAK-875, is a pill designed to enhance the secretion of insulin in response to such changes, which means that it has no effect on insulin secretion when blood sugar levels are normal -- potentially reducing the risk for hypoglycemia.

The trial, led by Dr. Charles Burant of the University of Michigan Medical School, included 426 patients with type 2 diabetes who were not getting adequate blood sugar control through diet, exercise or treatment with the first-line diabetes drug metformin.

The patients were randomly assigned to receive either TAK-875 (303 patients), placebo (61 patients), or another diabetes drug called glimepiride (brand named Amaryl).

The study was funded by Takeda Pharmaceutical (which is developing the drug), and appears online Feb. 26 in The Lancet.

After 12 weeks, all the patients taking the different doses of TAK-875 had significant drops in their blood sugar levels, the researchers said. A similar reduction occurred in patients taking glimepiride.

However, the incidence of episodes of hypoglycemia was much lower among patients taking TAK-875 (2 percent) than among those taking glimepiride (19 percent) and the same as those taking the placebo (2 percent).

The incidence of treatment-related side effects was 49 percent among patients taking TAK-875, 48 percent among those in the placebo group, and 61 percent among those in the glimepiride group, according to the researchers. Th
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. First-in-human drug for malignant glioma available in experimental trial
2. Experimental Drug Might Beat Aspirin in Preventing Repeat Strokes: Study
3. Experimental Drugs Do Battle Against Advanced Prostate Cancer
4. Experimental Blood Thinner Given Before Surgery Shows Benefit
5. Wolfson Foundation awards £20 million to UCL for experimental neurology center
6. Novel experimental agent is highly active in CLL patients, interim study shows
7. Experimental Drug for Irregular Heart Rhythm Raises Death Risk: Study
8. Experimental Drug Slims Obese Monkeys
9. Experimental Psoriasis Drug Bests Older Treatment
10. Experimental Vaccine Shows Promise for Lung Cancer: Study
11. Experimental vaccine protects monkeys from blinding trachoma
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Experimental Drug Shows Promise Against Type 2 Diabetes
(Date:7/29/2014)... Healthcare staffing agency Medical Solutions is ... Scholarship Competition winners:, ,     Alonso B., ...     Racheal D., Freshman, Cerritos College in Norwalk, CA ... in Houston, TX , Each year, ... the Nurses of Tomorrow Scholarship competition as a ...
(Date:7/29/2014)... 1WorldSync announces B. Braun Melsungen ... will utilize the Global Data Synchronization Network™ (GDSN®) ... share product information with the U.S. Food and ... their global supply chain. Holger Clobes, Head of ... "B. Braun serves customers in 61 countries, among ...
(Date:7/29/2014)... Mach7 Technologies, an award-winning provider of ... of an enhanced version of its Physician & ... & Patient Portal enables direct communication and collaboration ... a comprehensive view of their care history, including ... care records and intelligently delivers access to records ...
(Date:7/29/2014)... 2014 The Affordable Care Act has ... all hospitals. Studies show that over 400 hospitals probably ... low cost tool that great hospitals use to survive ... 25%. , Their secret? Debriefing - the simple process ... end of an operational event. Debriefing is a standard ...
(Date:7/29/2014)... July 29, 2014 TMG Health, ... solutions for health plans in the Medicare Advantage, ... markets recently held its annual Client Forum at ... the conference theme, “Partners in Excellence: Navigating the ... and operations leaders from TMG Health’s Client base ...
Breaking Medicine News(10 mins):Health News:Medical Solutions Announces Nurses of Tomorrow Scholarship Winners 2Health News:B. Braun Selects 1WorldSync Unique Device Identification and Product Information Solution 2Health News:B. Braun Selects 1WorldSync Unique Device Identification and Product Information Solution 3Health News:Mach7 Technologies’ Physician & Patient Portal Consolidates Patient Care Records across the Enterprise and Simplifies Image Sharing and Communication 2Health News:Mach7 Technologies’ Physician & Patient Portal Consolidates Patient Care Records across the Enterprise and Simplifies Image Sharing and Communication 3Health News:One Brilliant Economic Survival Tool You Can Steal from the World's Best Hospitals 2Health News:One Brilliant Economic Survival Tool You Can Steal from the World's Best Hospitals 3Health News:TMG Health Client Forum Explores Strategies for Success in the Post-Reform Market 2Health News:TMG Health Client Forum Explores Strategies for Success in the Post-Reform Market 3
... DALLAS, Oct. 27 , Robert A. Douglas, ... (RJR) , RJR Focus: SHC Career Division national sales ... over 20 years of previous sales management experience and over ... with SHC he has been fundamental in the development and ...
... ... Campus Compact and First Lady Michelle Obama for its commitment to public service and civic ... North Brunswick, NJ ... recognized at a gala luncheon hosted by the Florida Campus Compact and First Lady Michelle ...
... Calif., Oct. 27 Hauling multiple weapons into hunting grounds or ... those sportsmen who like to mix and match rifles and handguns. ... damage or lose prized possessions while in the hunt for big ... the new GunCruzer 2N2 Universal GunPod Case and wheel it to ...
... phones as far as possible from body, research suggests , MONDAY, ... hip may reduce bone density in an area of the pelvis ... researchers used dual X-ray absorptiometry to measure bone density at the ... carried their cell phones on their belts. The men carried their ...
... Ontario, Oct. 26 CardioGenics Holdings Inc. (OTC Bulletin Board: ... ticker symbol change for the Company on the OTCBB will ... 27, 2009. The new ticker symbol for "CardioGenics Holdings ... addition to the name and ticker symbol change that is ...
... Oct. 26 A free 40-minute webinar, ... , is being sponsored by Compirion Healthcare Solutions, ... Wisconsin. The webinar is premiering Wednesday, November 18th at ... http://www.compirion.com/webinars/seminar_healthcare_reform.cfm . This important webinar will ...
Cached Medicine News:Health News:Senior Healthcare Consultants and RJR Insurance Services, Inc. Announce 4th Quarter 2009 and 1st Quarter 2010 Sales Management Promotions 2Health News:Senior Healthcare Consultants and RJR Insurance Services, Inc. Announce 4th Quarter 2009 and 1st Quarter 2010 Sales Management Promotions 3Health News:Senior Healthcare Consultants and RJR Insurance Services, Inc. Announce 4th Quarter 2009 and 1st Quarter 2010 Sales Management Promotions 4Health News:Ross University School of Medicine Recognized for Commitment to Public Service and Civic Leadership 2Health News:CaseCruzer -- New GunCruzer 2N2Universal GunPod Case Makes Rifles and Handguns Travel Companions 2Health News:Cell Phone May Reduce Bone Density in Hips 2Health News:Free Webinar for CEOs on Preparing Your Hospital for Healthcare Reform 2Health News:Free Webinar for CEOs on Preparing Your Hospital for Healthcare Reform 3
(Date:7/29/2014)... , July 29, 2014  The BioFusionary ... on developing a proprietary electromagnetic induction platform with ... into an agreement under which TBC will merge ... Limited (COT) in an all-stock transaction. ... initially trade on the Australian Stock Exchange under ...
(Date:7/29/2014)... July 29, 2014 , ... clinical development program has commenced , TPM®/Oxycodone ... during Q4 2014 , TPM®/Oxymorphone Phase ... in 1H 2015 Australian drug delivery company, ... opioid transdermal patch programs after its recent announcement of a $19.2 ...
(Date:7/28/2014)... SAN FRANCISCO , July 28, 2014 /PRNewswire/ ... that it has received the Get With The ... quality improvement measures outlined by the American Heart ... patients. Stroke is the number four cause of ... in the United States , ...
Breaking Medicine Technology:The BioFusionary Corporation, Inc. Announces Intent To Complete Reverse Takeover Of Australia-Based Continuation Investments Limited 2The BioFusionary Corporation, Inc. Announces Intent To Complete Reverse Takeover Of Australia-Based Continuation Investments Limited 3Phosphagenics Provides Update on Opioid Patch Program 2Phosphagenics Provides Update on Opioid Patch Program 3Phosphagenics Provides Update on Opioid Patch Program 4Phosphagenics Provides Update on Opioid Patch Program 5Phosphagenics Provides Update on Opioid Patch Program 6Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 2Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: